Nerisone C

Nerisone C

Manufacturer:

LEO Pharma

Distributor:

DKSH
Concise Prescribing Info
Contents
Diflucortolone valerate 0.1%, chlorquinaldol 1%
Indications/Uses
Initial & interim treatment of corticoid-responsive dermatoses which are bacterially &/or mycotically infected as long as inflammatory symptoms predominate.
Dosage/Direction for Use
Apply bd-tds until remission, then once daily.
Contraindications
Tuberculous or syphilitic processes; viral diseases, 1st trimester of pregnancy.
Special Precautions
Avoid contact w/ eyes. Childn <4 yr (max 3 wk treatment). Do not apply to the face if rosacea or perioral dermatitis is present.
Adverse Reactions
Application to large body areas or for prolonged period: Skin atrophy; telangiectasia; striae & acneiform changes; perioral dermatitis, hypertrichosis, systemic effects; rarely, allergic skin reactions.
ATC Classification
D07BC04 - diflucortolone and antiseptics ; Belongs to the class of potent (group III) corticosteroids, in combination with antiseptics. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Nerisone C cream
Packing/Price
10 g x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in